Results 151 to 160 of about 59,669 (311)
Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus [PDF]
N. Costedoat‐Chalumeau+7 more
openalex +1 more source
This study investigated the therapeutic equivalence of CT‐P39 (an omalizumab biosimilar) and EU‐approved reference omalizumab (ref‐OMA) in patients with chronic spontaneous urticaria. Therapeutic equivalence between CT‐P39 and ref‑OMA (300 mg) was demonstrated by the primary endpoint – confidence intervals of the treatment difference in mean change ...
Sarbjit S. Saini+16 more
wiley +1 more source
Severe, Reversible Dysphagia from Chloroquine and Hydroxychloroquine Myopathy [PDF]
Farrah J. Mateen, B. Mark Keegan
openalex +1 more source
Abstract Purpose To assess and compare the characteristics, therapy interventions, occurrence of uveitis and ocular complications in children with juvenile idiopathic arthritis (JIA) screened and examined for uveitis in Gothenburg, Sweden, over 20 years.
Pia Lundgren+7 more
wiley +1 more source
730 Hydroxychloroquine (HCQ) in corticosteroid-dependent chronic urticaria (CDCU)
Joyce K. Lammert, Doreen Robinson
openalex +1 more source
Background and Purpose Systemic lupus erythematosus is an autoimmune, multisystemic disease affecting all organs in the body. Accrued evidence has elucidated a role for autophagy in the onset and severity of systemic lupus erythematosus. The antimalarial drug hydroxychloroquine constitutes the cornerstone of standard of care for systemic lupus ...
Eya Toumi+10 more
wiley +1 more source
Stopping the rot: the stories behind methotrexate, sulphasalazine and hydroxychloroquine [PDF]
Maree Micallef+2 more
openalex +1 more source
Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl+2 more
wiley +1 more source